McKesson Co. (NYSE:MCK) Shares Purchased by Brookstone Capital Management

Brookstone Capital Management boosted its position in McKesson Co. (NYSE:MCK - Free Report) by 42.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,473 shares of the company's stock after acquiring an additional 3,137 shares during the period. Brookstone Capital Management's holdings in McKesson were worth $5,969,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of MCK. Wolff Wiese Magana LLC increased its position in McKesson by 742.9% during the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company's stock worth $29,000 after purchasing an additional 52 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of McKesson in the 3rd quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new position in McKesson in the third quarter valued at $31,000. ORG Wealth Partners LLC purchased a new stake in McKesson during the third quarter valued at about $40,000. Finally, Bruce G. Allen Investments LLC increased its stake in McKesson by 51.9% during the fourth quarter. Bruce G. Allen Investments LLC now owns 82 shares of the company's stock worth $47,000 after acquiring an additional 28 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on MCK shares. Evercore ISI increased their target price on shares of McKesson from $560.00 to $680.00 and gave the stock an "outperform" rating in a research report on Thursday, November 7th. Baird R W upgraded shares of McKesson from a "hold" rating to a "strong-buy" rating in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft cut their target price on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a research note on Wednesday, September 25th. Robert W. Baird raised shares of McKesson from a "neutral" rating to an "outperform" rating and upped their price target for the stock from $531.00 to $688.00 in a research report on Thursday, November 7th. Finally, Mizuho began coverage on McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price target for the company. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $646.14.

McKesson Stock Down 1.7 %

Shares of McKesson stock traded down $10.22 during trading hours on Wednesday, hitting $583.51. 722,346 shares of the company's stock traded hands, compared to its average volume of 651,394. The stock has a 50 day simple moving average of $595.09 and a 200-day simple moving average of $560.90. The company has a market cap of $74.07 billion, a PE ratio of 30.22, a PEG ratio of 1.25 and a beta of 0.52. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. The company had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The company's revenue was up 21.3% on a year-over-year basis. During the same period last year, the firm earned $6.23 earnings per share. As a group, equities research analysts predict that McKesson Co. will post 32.73 EPS for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd were paid a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.49%. McKesson's dividend payout ratio (DPR) is presently 14.71%.

Insider Activity

In other news, EVP Leann B. Smith sold 579 shares of the company's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $602.81, for a total value of $349,026.99. Following the sale, the executive vice president now owns 1,443 shares in the company, valued at approximately $869,854.83. This represents a 28.64 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.11% of the company's stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.